» Articles » PMID: 14633718

Gene Expression and Mitotic Exit Induced by Microtubule-stabilizing Drugs

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Nov 25
PMID 14633718
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the molecular mechanisms underlying the actions of Taxol and the functionally related molecule epothilone B (EpoB), we have analyzed the gene expression profiles in A549 cells in response to increasing concentrations of these microtubule-stabilizing drugs. An almost identical expression pattern was observed in cells treated with either Taxol or EpoB. Low concentrations of the drugs induced aberrant mitosis including asymmetric and multipolar cell divisions. At drug concentrations that triggered G(2)-M arrest, cells escaped from a prolonged mitotic arrest without cell division, resulting in tetraploid G(1) cells. This mitotic slippage is correlated with diminished expression of cdc2 kinase, topoisomerase IIalpha, BUB3, and BUB2-like protein 1, as well as with an increased expression of 14-3-3-sigma. Poly(ADP-ribose) polymerase cleavage, an early indicator of apoptosis, occurred in cells undergoing mitotic slippage and in aneuploid cells resulting from aberrant mitosis. In contrast, cells arrested in mitosis demonstrated no signal for apoptosis but had an increased expression of survivin, an inhibitor of apoptosis. Induction of aneuploid or tetraploid G(1) cells was accompanied by increased expression of CD95, p21, and BTG2 that may contribute to cell death because their expression was diminished in an EpoB-resistant cell line. In contrast, expression of GADD45 and PTGF-beta could promote cell survival. We conclude that abnormal mitotic exit is required for apoptotic cell death induced by microtubule-stabilizing drugs.

Citing Articles

2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway.

Schaufelberger S, Schaettin M, Azzarito G, Rosselli M, Leeners B, Dubey R Cells. 2024; 13(13.

PMID: 38994940 PMC: 11240791. DOI: 10.3390/cells13131086.


The Involvement of Natural Polyphenols in Molecular Mechanisms Inducing Apoptosis in Tumor Cells: A Promising Adjuvant in Cancer Therapy.

Chimento A, De Luca A, DAmico M, De Amicis F, Pezzi V Int J Mol Sci. 2023; 24(2).

PMID: 36675194 PMC: 9863215. DOI: 10.3390/ijms24021680.


RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage.

Haynes B, Cunningham K, Shekhar M BMC Cancer. 2022; 22(1):1073.

PMID: 36258187 PMC: 9578210. DOI: 10.1186/s12885-022-10119-z.


Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities.

Morales D, Mousa S Heliyon. 2022; 8(5):e09517.

PMID: 35647354 PMC: 9136349. DOI: 10.1016/j.heliyon.2022.e09517.


Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses.

Contreras-Trujillo H, Eerdeng J, Akre S, Jiang D, Contreras J, Gala B Nat Commun. 2021; 12(1):6522.

PMID: 34764253 PMC: 8586369. DOI: 10.1038/s41467-021-26771-1.